Background: The elderly are perceived as a high-risk group for procedural sedation. Concern exists regarding the safety of sedation of this patient group by emergency physicians, particularly when using propofol. Methods: We analysed prospectively collected data on patients aged 75 yr or older undergoing sedation between October 2006 and March 2017 in the emergency department of a single centre. We used the World Society of Intravenous Anaesthesia International Sedation Task Force adverse event tool, stratifying identified adverse events according to consensus agreement. Results: Of 740 consecutive patients (median age 84 yr), 571 patients received propofol, 142 morphine and midazolam, and 27 other agents. We identified 19 sentinel events: 2 cases of hypoxaemia, 10 of apnoea (without hypoxaemia), 5 of hypotension, and 2 of both hypoxaemia and hypotension. We also identified 30 moderate, 41 minor, and 7 minimal risk adverse events. There were no adverse outcomes. Conclusions: We observed safe sedation practice in this high-risk group of patients. A sentinel adverse event rate of 2.6% including a hypoxaemia rate of 0.5% with no adverse outcomes sets a benchmark for sedation of the elderly.
safety analysis of 1008 adults sedated with propofol, we found that 6 of 11 patients with a sentinel adverse event were elderly. 5 In contrast, age was not a factor associated with complications in an analysis of 1402 adult patients in a Scottish ED. 6 As sedation is a common ED procedure, the UK population is ageing, and there is a perceived sedative risk in this patient group, we explored the safety of our service for the elderly in greater detail, irrespective of sedative agent used.
Methods
We conducted an observational study using a prospectively collected database of patients undergoing sedation in our EDdone seeing 60 000 patients in 2007, rising to 90 000 in 2016. We used either propofol, morphine and midazolam or on occasions ketamine or 70% nitrous oxide, the latter alone or possibly in combination with other agents. Propofol was given according to our published guideline. 7 This has evolved, and the current guideline is illustrated in Appendix A. Essentially patients received a 0.5e1 mg kg À1 bolus of propofol after 3 min of preoxygenation with a fraction of inspired oxygen (FiO 2 ) as close to 1 as possible. This was provided via a bag-valve-mask attached to high-flow oxygen and was continued until each patient was able to demonstrate adequate ventilatory effort. Smaller additional boluses were used for inadequate or prolonged sedation. Alternatively, morphine and midazolam was used with discretion (e.g. in the unwell, frail) or according to policy: senior physician unavailable. For all patients with fracture, dislocation, or both, i.v. morphine given by paramedic crews was typically supplemented with further boluses according to pain score and response, before radiological investigation. We used the American Society of Anesthesiologists (ASA) guideline on fasting requirements for elective surgery (adopted by the RCoA). On occasions, we allowed flexibility in clinically urgent cases (e.g. unstable patient requiring cardioversion, joint dislocation with neuropraxia) as previously discussed in a consensus-based clinical practice advisory. 8 We routinely risk assessed each patient's airway, using the respective ASA grading informally. We carefully considered the risk and benefit of procedural sedation, the target depth of sedation and selection of sedative agent(s 
Results
We identified and analysed 2931 patients. 740 of these were 75 yr or older. Three were excluded because they had their sedation delivered by anaesthetists. Figure 1 illustrates the proportion of patients that were arbitrarily grouped: 75e79, 80e84, and 85þ yr old. The ages ranged from 75 to 101 yr (median, 84 yr). A total of 208 patients were male, and 529 were female. The clinical indication for sedation is demonstrated (Fig. 2) . Overall, 571 patients received propofol, 142 morphine and midazolam, and 27 other agents. We identified 97 adverse events and stratified in accordance with the SIVA tool 19 of these as sentinel, 30 as moderate, 41 as minor, and 7 as a minimal risk adverse event. Of the sentinel cases, 2 related to hypoxaemia, 10 to apnoea (without hypoxaemia), 5 to hypotension requiring the need for pressor treatment, and 2 cases related to both hypoxaemia and hypotension. 5 of the 19 cases involved midazolam, 14 propofol. We describe each sentinel case in Table 1 . The number of sentinel events each year is depicted in Figure 3 . The sentinel event rate in each age group is demonstrated in Figure 4 . The overall sentinel adverse event rate was 2.6%. We failed to retrieve the original sedation chart in 70 patients, either because the chart had not been scanned (20), or the incorrect hospital number had been recorded on the database (27) or not recorded at all (23). We included all 70 patients within the analysis, using the evidence recorded within the database and where possible accessing the patients' hospital records. None of these had a sentinel adverse event; four had moderate. The remainder had either lesser or no adverse events.
Discussion
This study suggests that sedation practice for elderly patients in this department is safe. Although we recognise that the overall adverse event rate is more than twice that of our previous analysis of sedated adults (2.6% vs 1.1%), the incidence of hypoxia was 0.5% in both studies. This compares favourably with hypoxia rates identified with electronically recorded pulse oximetry during non-cardiac adult anaesthesia of 10.3%. 10 Ten of the 19 sentinel cases in our series had neither hypoxia nor hypotension. There were no adverse outcomes. On analysis, two particular points are noteworthy. Firstly, as per our previous recommendation 5 a smaller propofol bolus (0.5 mg kg
À1
) and smaller subsequent boluses (0.25 mg kg À1 ) may have limited or prevented both respiratory and cardiovascular complications. Only three (cases 12, 13, and 18) of the 14 sentinel patients given propofol had the doses in line with this recommendation. This likely represents a responsive change in practice from 2013. Secondly, the merit of quality preoxygenation (as per propofol protocol) protected the majority of apnoeic patients from hypoxaemia: nine of the 12 patients meeting the World SIVA definition of apnoea did not become hypoxaemic.
The number of adverse events per year (Fig. 4 ) appears patternless. Neither is it possible to draw any meaningful conclusions when comparing event rates between propofol and morphine and midazolam. The latter combination may have deliberately been selected for the frail elderly; on deeper analysis all five sentinel events were supervised by a consultant, confounding the notion that these would be more likely with a lone middle grade, a risk factor previously identified by Scottish colleagues. 6 The sentinel event rate in the three age groups (Fig. 3 ) fails to demonstrate a trend; the increased rate in the most elderly group is not statistically significant. The adverse event rate of 2.6% nevertheless endorses caution: robust training and governance is required to support their sedation.
We recognise limitations to our study. The first is the (likely) poor recording of prolonged apnoea in the database and sedation charts. Propofol typically causes brief apnoea or change in respiratory pattern at onset, and the duration of this may not be accurately timed, especially when expected and not associated with hypoxaemia because of appropriate use of preoxygenation. Secondly, intermittent recording of saturation values could potentially miss brief but significant desaturation episodes. Future study might therefore incorporate continuous electronic saturation data capture. Thirdly, there is also the possibility of variable reporting of events by staff. However, real-time recording of data onto the e-database is mandated in the department and reinforced on annual, open audit as part of the governance framework. Finally, there is the failure to find and cross-examine the original sedation chart of 73 patients. Variability in reporting might also be improved by use of a validated sedation outcomes reporting tool. 11 In conclusion, we have demonstrated safe sedation practice in this high-risk group of patients by emergency medicine personnel in this ED, as has been shown previously in paediatric patients. 12, 13 A sentinel adverse event rate of 2.6%
including a hypoxaemia rate of 0.5%, with no adverse outcomes sets a benchmark for elderly sedation. We recommend quality pre-oxygenation, an initial propofol bolus of no more than 0.5 mg kg À1 (and subsequent doses of 0.25 mg kg
), and a robust training and governance framework.
